| Alhemo 60 mg/1.5 mL solution for injection in pre-filled pen EU/1/24/1881/003-004 |
Concizumab |
Novo Nordisk A/S |
— |
| Alimta EU/1/04/290/002 |
Pemetrexed |
Eli Lilly Nederland B.V. |
— |
| Alimta 500 mg powder for concentrate for solution for infusion EU/1/04/290/001 |
Pemetrexed |
Eli Lilly Nederland B.V. |
— |
| Alkindi 0.5 mg granules in capsules for opening EU/1/17/1260/001 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| Alkindi 1 mg granules in capsules for opening EU/1/17/1260/002 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| Alkindi 2 mg granules in capsules for opening EU/1/17/1260/003 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| Alkindi 5 mg granules in capsules for opening EU/1/17/1260/004 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| Alli EU/1/07/401/12-15 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Alli EU/1/07/401/1-6 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Alli EU/1/07/401/7-11 |
Orlistat |
GlaxoSmithKline Dungarvan Limited |
— |
| Aloxi 250 micrograms solution for injection EU/1/04/306/001 |
Palonosetron (as hydrochloride) |
Helsinn Birex Pharmaceuticals Limited |
— |
| Aloxi 500 micrograms soft capsules EU/1/04/306/002-003 |
Palonosetron (as hydrochloride) |
Helsinn Birex Pharmaceuticals Limited |
— |
| ALPROLIX 1000 IU powder and solvent for solution for injection EU/1/16/1098/003 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 2000 IU powder and solvent for solution for injection EU/1/16/1098/004 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 250 IU powder and solvent for solution for injection EU/1/16/1098/001 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 3000 IU powder and solvent for solution for injection EU/1/16/1098/005 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALPROLIX 500 IU powder and solvent for solution for injection EU/1/16/1098/002 |
Eftrenonacog alfa |
Swedish Orphan Biovitrum AB |
— |
| ALTUVOCT 1 000 IU Powder and solvent for solution for injection EU/1/24/1824/004 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 2 000 IU Powder and solvent for solution for injection EU/1/24/1824/005 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 250 IU Powder and solvent for solution for injection EU/1/24/1824/001 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 3 000 IU Powder and solvent for solution for injection EU/1/24/1824/006 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 4 000 IU Powder and solvent for solution for injection EU/1/24/1824/007 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 500 IU Powder and solvent for solution for injection EU/1/24/1824/002 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| ALTUVOCT 750 IU Powder and solvent for solution for injection EU/1/24/1824/003 |
Efanesoctocog alfa |
Swedish Orphan Biovitrum AB(publ) |
— |
| Alunbrig 180 mg film-coated tablets EU/1/18/1264/009-010 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alunbrig 30 mg film-coated tablets EU/1/18/1264/001-004 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alunbrig 90 mg film-coated tablets EU/1/18/1264/005-008 |
Brigatinib |
Takeda Pharma A/S |
— |
| Alvesco 160 micrograms pressurised inhalation, solution PA22986/001/002 |
Ciclesonide |
Covis Pharma Europe B.V. |
Marketed |
| Alvesco 80 micrograms pressurised inhalation, solution PA22986/001/001 |
Ciclesonide |
Covis Pharma Europe B.V. |
Marketed |
| Alyftrek 125 mg/50 mg/10 mg film-coated tablets EU/1/25/1943/002 |
Vanzacaftor, TEZACAFTOR, Deutivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Alyftrek 50 mg/20 mg/4 mg film-coated tablets EU/1/25/1943/001 |
Vanzacaftor, TEZACAFTOR, Deutivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Alymsys 25 mg/mL concentrate for solution for infusion EU/1/20/1509/001-002 |
Bevacizumab |
Mabxience Research, S.L. |
— |
| Amantadine hydrochloride Renata 100 mg Capsules, hard PA22865/005/001 |
AMANTADINE HYDROCHLORIDE |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Ambirix suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/005 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/001 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/002 |
Hepatitis b surface antigen (hbs ag), Hepatitis a virus |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/003 |
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/004 |
Hepatitis a virus, Hepatitis b surface antigen (hbs ag) |
GlaxoSmithKline Biologicals S.A. |
— |
| Ambrisentan Viatris 10 mg film-coated tablets EU/1/19/1368/003-004 |
Ambrisentan |
Viatris Limited |
— |
| Ambrisentan Viatris 5 mg film-coated tablets EU/1/19/1368/001-002 |
Ambrisentan |
Viatris Limited |
— |
| Ameluz 78 mg/g gel EU/1/11/740/001 |
5-aminolevulinic acid hydrochloride |
Biofrontera Bioscience GmbH |
— |
| AMGEVITA 20 mg solution for injection in pre-filled syringe EU/1/16/1164/001 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGEVITA 20 mg solution for injection in pre-filled syringe EU/1/16/1164/010 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGEVITA 40 mg solution for injection in pre-filled pen EU/1/16/1164/014- 016 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGEVITA 40 mg solution for injection in pre-filled syringe EU/1/16/1164/002-009 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGEVITA 40 mg solution for injection in pre-filled syringe EU/1/16/1164/011-013 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGEVITA 80 mg solution for injection in pre-filled pen EU/1/16/1164/020- 022 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGEVITA 80 mg solution for injection in pre-filled syringe EU/1/16/1164/017-019 |
Adalimumab |
Amgen Europe B.V., |
— |
| AMGLIDIA 0.6 mg/mL oral suspension EU/1/18/1279/001-002 |
Glibenclamide |
AMMTek |
— |
| AMGLIDIA 6 mg/mL oral suspension EU/1/18/1279/003-004 |
Glibenclamide |
AMMTek |
— |